Its a distinctly different tool with its own merits and indications
Because autoimmune conditions can prevent proper absorption of B12, these patients are at increased risk of deficiency
BPC-157 may be purchased in the UK when supplied and used strictly for laboratory research purposes
When to Choose BPC-157: The Single-Site Injury Profile BPC-157 at $445 per cycle at Perfect B is the right choice when the injury is specific, accessible, and localized enough that subcutaneous injection can consistently reach the damaged tissue
Commonly Reported Side Effects Mild injection site irritation or redness Headache or fatigue (usually transient in early dosing) Nausea (rare, typically with higher doses or fasted use) In human trials, AOD9604 demonstrated a strong safety profile with no significant adverse effects or changes in glucose, insulin, or organ size. Heffernan et al., Journal of Endocrinology No IGF-1 Elevation or Growth Risks Unlike hGH, AOD9604 does not stimulate systemic growth meaning: No risk of acromegaly or organ hypertrophy No increase in cancer risk tied to IGF-1 elevation No suppression of natural hormone production Not a Controlled Substance AOD9604 is not scheduled or classified as a controlled substance in the U.S